Sponsor pipeline

Kathy Miller clinical trial pipeline

Get alerts when Kathy Miller's trials change

1 active trials 1 recruiting 2 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-09-04
critical
Primary completion pushed: 2026-12 → 2027-12
Primary endpoint(s) modified
Interventions modified
Completion pushed: 2026-12 → 2027-12
NCT05846789 Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast… · Phase 2

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT05846789 Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast… Metastatic Breast Cancer Recruiting 2026-09-03

Disease areas by active trials

Get alerts when Kathy Miller's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free